Gene therapy, gene targeting and induced pluripotent stem cells: applications in monogenic disease treatment

Biotechnology Advances
Gabriel Kun Yung Wong, Andrew T Chiu

Abstract

Monogenic diseases are often severe, life-threatening disorders for which lifelong palliative treatment is the only option. Over the last two decades, a number of strategies have been devised with the aim to treat these diseases with a genetic approach. Gene therapy has been under development for many years, yet suffers from the lack of an effective and safe vector for the delivery of genetic material into cells. More recently, gene targeting by homologous recombination has been proposed as a safer treatment, by specifically correcting disease-causing mutations. However, low efficiency is a major drawback. The emergence of two technologies could overcome some of these obstacles. Terminally differentiated somatic cells can be reprogrammed, using defined factors, to become induced pluripotent stem cells (iPSCs), which can undergo efficient gene mutation correction with the aid of fusion proteins known as zinc finger nucleases (ZFNs). The amalgamation of these two technologies has the potential to break through the current bottleneck in gene therapy and gene targeting.

References

Jun 16, 1989·Science·M R Capecchi
May 10, 1994·Proceedings of the National Academy of Sciences of the United States of America·Y YangJ M Wilson
Jun 1, 1996·Trends in Genetics : TIG·M Jasin
May 27, 1997·Proceedings of the National Academy of Sciences of the United States of America·Q LiuC F Barbas
Apr 18, 1998·Proceedings of the National Academy of Sciences of the United States of America·J S Kim, C O Pabo
Apr 16, 1998·Nature Genetics·D W Russell, R K Hirata
Sep 2, 1998·Proceedings of the National Academy of Sciences of the United States of America·D A WahA K Aggarwal
Nov 6, 1998·Science·J A ThomsonJ M Jones
May 1, 1999·Trends in Genetics : TIG·J M Sedivy, A Dutriaux
Apr 28, 2000·Science·M Cavazzana-CalvoA Fischer
Jun 7, 2000·Proceedings of the National Academy of Sciences of the United States of America·T TakenakaJ A Medin
Aug 10, 2000·Molecular Therapy : the Journal of the American Society of Gene Therapy·P L Zeitlin
Nov 23, 2000·Proceedings of the National Academy of Sciences of the United States of America·S HatadaO Smithies
Feb 28, 2001·Proceedings of the National Academy of Sciences of the United States of America·S C JungP Qasba
Mar 15, 2001·Proceedings of the National Academy of Sciences of the United States of America·G QinJ A Medin
Sep 12, 2001·Medicine·M H Steinberg, G P Rodgers
Jan 19, 2002·Nature Genetics·Daniel G MillerDavid W Russell
Oct 9, 2002·Proceedings of the National Academy of Sciences of the United States of America·Hiroshi TakahashiTakashi Shimada
Feb 11, 2003·Nature Biotechnology·Thomas P Zwaka, James A Thomson
Mar 8, 2003·Proceedings of the National Academy of Sciences of the United States of America·Jinhee ParkPankaj Qasba
Dec 12, 2003·Cancer Cell·Sharon GidekelEli Pikarsky
Feb 21, 2004·Science·Joel R ChamberlainDavid W Russell
Apr 23, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ashka Y PandyaJ Michael Ruppert
Jul 28, 2004·Stem Cells·Achiya UrbachNissim Benvenisty
Oct 20, 2004·Trends in Biotechnology·T MontierP Midoux
Nov 20, 2004·Proceedings of the National Academy of Sciences of the United States of America·Makoto YoshimitsuJeffrey A Medin
Nov 25, 2004·Hematology·George R BuchananMartin H Steinberg
Aug 6, 2005·Nature Biotechnology·Matthew H Porteus, Dana Carroll
Oct 28, 2005·Nucleic Acids Research·Sundar DuraiSrinivasan Chandrasegaran
Nov 1, 2005·Proceedings of the National Academy of Sciences of the United States of America·Seigo HatadaOliver Smithies
Mar 18, 2006·Nature Reviews. Genetics·Timothy P O'Connor, Ronald G Crystal
May 10, 2006·Molecular Therapy : the Journal of the American Society of Gene Therapy·Peter BellJames M Wilson

❮ Previous
Next ❯

Citations

Dec 3, 2011·Nucleic Acids Research·Benno SchierlingAlfred Pingoud
Jul 3, 2013·Pharmacological Reviews·George J ChristKarl-Erik Andersson
Sep 29, 2015·Molecular Metabolism·Adrian Kee Keong TeoRohit N Kulkarni
Feb 9, 2017·Stem Cells Translational Medicine·Scott BellCarl Ernst
Jun 30, 2019·Stem Cells·Stuart P Atkinson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell-Type-Specific Viral Vectors (ASM)

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CFTR Mutant Structural Therapy

Over 1700 different mutations in the CFTR genes have been shown to cause cystic fibrosis. Here is the latest research on structural therapy for CFTR mutants.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Artificial Chromosomes

Artificial chromosomes are genetically engineered chromosomes derived from the DNA of a species. Discover the latest research on artificial chromosomes here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Cell-Type Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Cell-Type-Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.